Explore
Validate
LearnBMS124
antibody from Invitrogen Antibodies
Targeting: CD44
CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1
Other assayAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- BMS124 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- CD44var (v3-v10) Polyclonal Antibody, eBioscience™
- Antibody type
- Polyclonal
- Antigen
- Other
- Description
- Description: Specifically recognizes an epitope encoded by exons v3-v10 on the variant portion of human CD44.
- Concentration
- 1 mg/mL
Submitted references CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Yu YH, Morales J, Feng L, Lee JJ, El-Naggar AK, Vigneswaran N
Oral surgery, oral medicine, oral pathology and oral radiology 2015 May;119(5):553-65
Oral surgery, oral medicine, oral pathology and oral radiology 2015 May;119(5):553-65
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
Berner HS, Suo Z, Risberg B, Villman K, Karlsson MG, Nesland JM
Histopathology 2003 Jun;42(6):546-54
Histopathology 2003 Jun;42(6):546-54
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- NULL
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- 1 Immunohistochemical detection of CD44 molecules in breast carcinomas. CD44s protein expression showing strong membranous and cytoplasmic staining, CD44v5 protein expression showing cytoplasmic staining, CD444v6 protein expression showing both membranous and cytoplasmic staining, while CD44v7 and CD44v3-10 protein expression shows cytoplasmic staining.
